Table 1 Demographic features of the patients.

From: A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes

 

Controls n = 15

MDS n = 95

Age (years)

40 (31–52)

67 (33–79)

Male/female

9/6

62/33

IPSS-R

  

  Very low risk

 

13

  Low risk

 

34

  Intermediate

 

24

  High risk

 

17

  Very high risk

 

7

 WHO types

  

 Refractory anemia

 

6

 5q-syndrome

 

2

 RCMD*

 

61

RAEB I**

 

12

RAEB II**

 

14

  1. *Refractory cytopenia with multilineage dysplasia, **Refractory anemia with excess of blasts.
Back to article page